Cargando…
Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer
BACKGROUND: A huge focus is being placed on the development of novel signatures in the form of new combinatorial regimens to distinguish the neuroendocrine (NE) characteristics from castration resistant prostate cancer (CRPC) timely and accurately, as well as predict the disease-free survival (DFS)...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849576/ https://www.ncbi.nlm.nih.gov/pubmed/36686485 http://dx.doi.org/10.3389/fendo.2022.1005916 |